Yehuda Handelsman to Biomarkers
This is a "connection" page, showing publications Yehuda Handelsman has written about Biomarkers.
Connection Strength
0.335
-
PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review. J Am Heart Assoc. 2018 06 22; 7(13).
Score: 0.137
-
Diabetes treatment over age 65: Is worse control really better? J Diabetes. 2017 May; 9(5):428-430.
Score: 0.125
-
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects. Vasc Health Risk Manag. 2020; 16:403-418.
Score: 0.040
-
JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1). J Clin Lipidol. 2017 May - Jun; 11(3):587-595.
Score: 0.032